[1]
Kashif Khalid et al. 2025. "EVALUATING ANTIDIABETIC DRUG THERAPIES IN PATIENTS WITH POLYCYSTIC OVARY SYNDROME: BIOCHEMICAL IMPACT AND CARDIOVASCULAR BENEFITS OF SGLT2 INHIBITORS - A CROSS-SECTIONAL STUDY". Journal of Population Therapeutics and Clinical Pharmacology. 32, 9 (Oct. 2025), 1464–1471. DOI:https://doi.org/10.53555/mzmf6t81.